Dana Stromberger

Analyze sales and operational data, develop and implement strategic sales plans, and cultivate external relationships to produce a high-performing territory. Proven ability to effectively manage key accounts, secure new accounts, drive sales performance, and achieve sales goals. Strong leadership skills, with a focus on mentoring and empowering team members to excel and contribute to a cohesive sales strategy. Committed to delivering results and contributing to the long-term success of the organization.

• Strategic Sales Planning
• Key Account Management
• Sales Performance Analysis
• Team Leadership and Development
• Market Research and Competitive Analysis
• Organic Growth Strategy

Responsible for the product launch of Roxybond, the first and only abuse-deterrent immediate-release Oxycodone. Analyze the payer landscape to understand the local healthcare environment on reimbursement, coverage, healthcare delivery models, patient pathways, buy and bill, and specialty pharmacy to identify and leverage business opportunities. Launched a national partnership with a wholesaler and specialty pharmacy to improve pull-through/push-through efforts to improve Rx Channels and efficiency.

• 800% growth Q4 v Q3 2023
• contract ended

CPT Business Unit selling SCS and DRG implantable devices. Responsible for the growth and profitability of the CPT portfolio and penetration of established/new accounts to gain additional revenue. Delivers results by partnering with implanting physicians, training new physicians, and establishing a consistent referral flow.

• President's Club Winner 2022
• 175% Goal Attainment producing 1.3 million over quota
• CPT restructure

Neurology Business Unit independently launching Dayvigo to high volume Psychiatry and Pain Management Accounts for Chronic Insomnia. Increased sales revenue by developing and implementing strategic sales plans.

• District Leadership award 2020
• Appointed District and National payer market liaison 2020
• Ranked 16th nationally 2020
• Analytics District Champion 2021
• Company Downsized

Promoted Morphabond, the first and only abuse-deterrent extended-release Morphine. Effectively managed resources to maximize business opportunities within my territory. Utilized data sources to analyze and capitalize on growth opportunities. Implemented CRM tool to track client interactions, optimizing follow-up procedues for better results.

• Regional Sales Trainer 2018 and 2019
• Ranked 1st in Nation Q3 2018 and Q2 2019
• Ranked 3rd in Nation Q1 2019
• Ranked 4th in Nation Q2 2018
• Company Closed

Promoted Nucynta immediate-release, Nucynta extended-release, Cambia and Gralise to high volume Pain Management and Neurology Accounts. Educated customers about product features to aid in selecting best options for each patients individual needs. Managed sales pipeline effectively, prioritizing tasks to maximize revenue potential.

• Achieved Product Portfilio Attainment of 117% 2017
• Ranked 39th Nationally 2017
• District Sales Trainer 2017
• Company Closed

Product Launch of Hysingla and Butrans for Chronic Pain, as well as, Intermezzo for Insomnia. Promoted Ryzolt and OxyContin for the treatment of moderate to severe chronic pain when alternate treatment options are inadequate. Streamlined process for better efficiency, such as optimizing sales routes and utilizing CRM tools effectively. Integrated innovative ideas to accomplish corporate and individual objectives. Drove year-over-year business growth while leading operations, strategic vision, and long-range planning. Improved team performance by conducting regular coaching sessions and sharing best practices among members.

• Ranked 32nd Nationally for OxyContin 2014
• Finished top 15% Nationally 2015
• Finished top 10% Regionally 2015
• District Field Trainer 2013 and 2016
• Managed Markets Liaison 2015 and 2016
• Appointed into Mentorship Program 2016
• Ranked 1st Butrans launch 2012

Launched Azor and Tribenzor indicated for treatment of hypertension to lower patients blood pressure. Promoted Benicar, Benicar HCT, WelChol, and Floxin Otic to Cardiologist, Endocrinologist, Primary Care, Internal Medicine, and ENT's. Increased sales revenue by identifying and targeting high-potential accounts. Consistently met or exceeded quotas by implementing strategic sales plans and effective time management. Increased repeat business by fostering trust-based relationships with key accounts through regular communication.

• Ranked 33rd in Nation 2007 Azor Launch
• Platinum Performance Award 2007